TOPICAL ANTIGLAUCOMA COMPOSITION CONTAINING CARBONIC ANHYDRASE INHIBITOR AND BETA-BLACKER
展开▼
机译:含有碳酸酐酶抑制剂和β-黑啤酒的局部抗青光眼组合物
展开▼
页面导航
摘要
著录项
相似文献
摘要
PROBLEM TO BE SOLVED: To obtain the subject composition, capable of enhancing the compliance of a patient with no or slight adverse effects and effective in treating glaucoma and intraocular hypertension by including a -blocker and a carbonic anhydrase inhibitor (CAI) therein. SOLUTION: This composition is obtained by including one or more - blockers represented by formula I [R'1 is a (substituted)ring or a (substituted) aliphatic parts; R'2 and R'3 are each H or a (substituted)alkyl] and one or more carbonic anhydrase inhibitors represented by formula II [R1 is H, a 1-4C alkyl, OH, etc.; R2 is H, a 1-8C alkyl, OH, etc.; R3 is H, a halogen, a 1-4C alkyl, etc.; G is SO2 , C(=O), etc.] at (1:1) to (1:40) weight ratio. The composition is preferably an aqueous one and the pH thereof is 5.0-7.8. Furthermore, 0.05-2.0 wt.% anionic mucomimetic polymer having carboxylic acid functional groups or 0.05-10.0 wt.% drug transport substrate capable of selectively adsorbing or binding to a drug molecule or both can be contained in the composition in order to further sustain the release.
展开▼
机译:要解决的问题:为了获得主题组合物,通过在其中包括β-阻滞剂和碳酸酐酶抑制剂(CAI),该组合物能够增强患者的依从性而无不良影响或仅有轻微不良反应,并且能够有效治疗青光眼和眼内高压。溶液:该组合物是通过包含一种或多种由式I表示的嵌段基团[R'1是(取代的)环或(取代的)脂族部分; R′2和R′3分别为H或(取代的)烷基]和一种或多种式II表示的碳酸酐酶抑制剂[R1为H,1-4C烷基,OH等; R 2为H,1-8C烷基,OH等; R 3为H,卤素,1-4C烷基等。 G为(1:1)至(1:40)重量比的SO 2,C(= O)等。该组合物优选是水性的,其pH为5.0-7.8。此外,在组合物中可以含有0.05-2.0重量%的具有羧酸官能团的阴离子型拟模聚合物或0.05-10.0重量%的能够选择性地吸附或结合至药物分子或两者的药物转运底物,以进一步维持药物的活性。发布。
展开▼